Threat Assessment Brief: Reinfection with SARS-CoV-2: considerations for public health response

Risk assessment
Cite:
Citation Link

European Centre for Disease Prevention and Control. Reinfection with SARS-CoV: considerations for public health response: ECDC; 2020

Copy citation to clipboard

Cases with suspected or possible reinfection with SARS-CoV-2 have been recently reported in different countries. In many of these cases, it is uncertain if the individual’s Polymerase Chain Reaction (PCR) test remained positive for a long period of time following the first episode of infection or whether it represents a true reinfection.

The aim of this Threat Assessment Brief is to elucidate the characteristics and frequency of confirmed SARS-CoV-2 reinfection in the literature, to summarise the findings about SARS-CoV-2 infection and antibody development, and to consider the following questions:
• How can a SARS-CoV-2 reinfection be identified?
• How common are SARS-CoV-2 reinfections?
• What is known about the role of reinfection in onward transmission?
• What do these observations mean for acquired immunity?

Finally, options for public health response are proposed.

Related content

Publication

Reinfection with SARS-CoV-2: implementation of a surveillance case definition within the EU/EEA

Technical report -

Publication

Rollout of COVID-19 vaccines in the EU/EEA: challenges and good practice

Technical report -

Publication

Overview of the implementation of COVID-19 vaccination strategies and vaccine deployment plans in the EU/EEA

Technical report -

Publication

Risk of SARS-CoV-2 transmission from newly-infected individuals with documented previous infection or vaccination

Technical report -

Publication

Stress test on logistical aspects of COVID-19 vaccination deployment plans for the Western Balkans: final report

Technical report -